Is AbbVie Stock a Buy Now?
AbbVie (ABBV -0.30%) closed out a pivotal 2024 with an excellent fourth-quarter earnings report. For the period ended Dec. 31, […]
AbbVie (ABBV -0.30%) closed out a pivotal 2024 with an excellent fourth-quarter earnings report. For the period ended Dec. 31, […]
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.
Workers picket in front of an Amazon Logistic Station on December 19, 2024 in Skokie Illinois. Scott Olson | Getty
By Suzanne McGee (Reuters) – Asset managers, ranging from wealth management companies to hedge funds and pension funds, boosted allocations
This week was a choppy one for cryptocurrencies. As a group they mostly sank in value initially before rebounding strongly
Key Takeaways OpenAI rejected a reported $97.4 billion takeover offer from an Elon Musk-led investor group. OpenAI Chair Bret Taylor
Top crypto angel investor and Inversion Capital founder Santiago Roel Santos is tackling one of crypto’s biggest challenges: adoption. By
Key Takeaways Berkshire Hathaway entered a new position in Modelo maker Constellation Brands in Q4 2024. Buffett’s company, which is
Key Takeaways Elon Musk’s xAI company is reportedly meeting with investors about a potential $10 billion funding round that could
Key Takeaways Apple CEO Tim Cook said a product launch event is coming Wednesday. Analysts have speculated the company could